The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global PD-1 and PD-L1 Monoclonal Antibody Market Research Report 2025

Global PD-1 and PD-L1 Monoclonal Antibody Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1683560

No of Pages : 90

Ask Your Query
Synopsis
The global PD-1 and PD-L1 Monoclonal Antibody market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
PD-1/PD-L1 monoclonal antibody is an anti-tumor drug developed for the mechanism of tumor cell escape from T cell attack. By blocking the interaction between PD-L1 and PD-1, the ability of T cells to attack tumors is restored. The immunotherapy developed based on this has a broad-spectrum effect in the field of tumor treatment, showing significant therapeutic effects in various tumor treatments such as lung cancer, kidney cancer, colon cancer, ovarian cancer, liver cancer, melanoma, etc. At present, the industry pattern of PD-1/PD-L1 monoclonal antibody in China is gradually shaping, and the development prospects are gradually stabilizing. The future product effectiveness, potential demand for indications, and the ability of sales teams will be the core competitiveness of PD-1/PD-L1 monoclonal antibody products.
This report aims to provide a comprehensive presentation of the global market for PD-1 and PD-L1 Monoclonal Antibody, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding PD-1 and PD-L1 Monoclonal Antibody.
Report Scope
The PD-1 and PD-L1 Monoclonal Antibody market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global PD-1 and PD-L1 Monoclonal Antibody market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the PD-1 and PD-L1 Monoclonal Antibody manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merk
Bristol-Myers Squibb Company
Roche
Pfizer
AstraZeneca
Junshi Biosciences
Innovent
Hengrui
BeiGene
Alphamab Oncology
Cstone
Akeso
Henlius Biotech
Lepu Biopharma
Segment by Type
PD-1
PD-L1
Segment by Application
Hospital
Other Medical Institutions
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of PD-1 and PD-L1 Monoclonal Antibody manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of PD-1 and PD-L1 Monoclonal Antibody in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index
1 PD-1 and PD-L1 Monoclonal Antibody Market Overview
1.1 Product Overview and Scope of PD-1 and PD-L1 Monoclonal Antibody
1.2 PD-1 and PD-L1 Monoclonal Antibody Segment by Type
1.2.1 Global PD-1 and PD-L1 Monoclonal Antibody Market Value Comparison by Type (2024-2030)
1.2.2 PD-1
1.2.3 PD-L1
1.3 PD-1 and PD-L1 Monoclonal Antibody Segment by Application
1.3.1 Global PD-1 and PD-L1 Monoclonal Antibody Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Other Medical Institutions
1.4 Global PD-1 and PD-L1 Monoclonal Antibody Market Size Estimates and Forecasts
1.4.1 Global PD-1 and PD-L1 Monoclonal Antibody Revenue 2019-2030
1.4.2 Global PD-1 and PD-L1 Monoclonal Antibody Sales 2019-2030
1.4.3 Global PD-1 and PD-L1 Monoclonal Antibody Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 PD-1 and PD-L1 Monoclonal Antibody Market Competition by Manufacturers
2.1 Global PD-1 and PD-L1 Monoclonal Antibody Sales Market Share by Manufacturers (2019-2024)
2.2 Global PD-1 and PD-L1 Monoclonal Antibody Revenue Market Share by Manufacturers (2019-2024)
2.3 Global PD-1 and PD-L1 Monoclonal Antibody Average Price by Manufacturers (2019-2024)
2.4 Global PD-1 and PD-L1 Monoclonal Antibody Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of PD-1 and PD-L1 Monoclonal Antibody, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of PD-1 and PD-L1 Monoclonal Antibody, Product Type & Application
2.7 PD-1 and PD-L1 Monoclonal Antibody Market Competitive Situation and Trends
2.7.1 PD-1 and PD-L1 Monoclonal Antibody Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest PD-1 and PD-L1 Monoclonal Antibody Players Market Share by Revenue
2.7.3 Global PD-1 and PD-L1 Monoclonal Antibody Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 PD-1 and PD-L1 Monoclonal Antibody Retrospective Market Scenario by Region
3.1 Global PD-1 and PD-L1 Monoclonal Antibody Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global PD-1 and PD-L1 Monoclonal Antibody Global PD-1 and PD-L1 Monoclonal Antibody Sales by Region: 2019-2030
3.2.1 Global PD-1 and PD-L1 Monoclonal Antibody Sales by Region: 2019-2024
3.2.2 Global PD-1 and PD-L1 Monoclonal Antibody Sales by Region: 2025-2030
3.3 Global PD-1 and PD-L1 Monoclonal Antibody Global PD-1 and PD-L1 Monoclonal Antibody Revenue by Region: 2019-2030
3.3.1 Global PD-1 and PD-L1 Monoclonal Antibody Revenue by Region: 2019-2024
3.3.2 Global PD-1 and PD-L1 Monoclonal Antibody Revenue by Region: 2025-2030
3.4 North America PD-1 and PD-L1 Monoclonal Antibody Market Facts & Figures by Country
3.4.1 North America PD-1 and PD-L1 Monoclonal Antibody Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America PD-1 and PD-L1 Monoclonal Antibody Sales by Country (2019-2030)
3.4.3 North America PD-1 and PD-L1 Monoclonal Antibody Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe PD-1 and PD-L1 Monoclonal Antibody Market Facts & Figures by Country
3.5.1 Europe PD-1 and PD-L1 Monoclonal Antibody Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe PD-1 and PD-L1 Monoclonal Antibody Sales by Country (2019-2030)
3.5.3 Europe PD-1 and PD-L1 Monoclonal Antibody Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific PD-1 and PD-L1 Monoclonal Antibody Market Facts & Figures by Country
3.6.1 Asia Pacific PD-1 and PD-L1 Monoclonal Antibody Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific PD-1 and PD-L1 Monoclonal Antibody Sales by Country (2019-2030)
3.6.3 Asia Pacific PD-1 and PD-L1 Monoclonal Antibody Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America PD-1 and PD-L1 Monoclonal Antibody Market Facts & Figures by Country
3.7.1 Latin America PD-1 and PD-L1 Monoclonal Antibody Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America PD-1 and PD-L1 Monoclonal Antibody Sales by Country (2019-2030)
3.7.3 Latin America PD-1 and PD-L1 Monoclonal Antibody Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa PD-1 and PD-L1 Monoclonal Antibody Market Facts & Figures by Country
3.8.1 Middle East and Africa PD-1 and PD-L1 Monoclonal Antibody Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa PD-1 and PD-L1 Monoclonal Antibody Sales by Country (2019-2030)
3.8.3 Middle East and Africa PD-1 and PD-L1 Monoclonal Antibody Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global PD-1 and PD-L1 Monoclonal Antibody Sales by Type (2019-2030)
4.1.1 Global PD-1 and PD-L1 Monoclonal Antibody Sales by Type (2019-2024)
4.1.2 Global PD-1 and PD-L1 Monoclonal Antibody Sales by Type (2025-2030)
4.1.3 Global PD-1 and PD-L1 Monoclonal Antibody Sales Market Share by Type (2019-2030)
4.2 Global PD-1 and PD-L1 Monoclonal Antibody Revenue by Type (2019-2030)
4.2.1 Global PD-1 and PD-L1 Monoclonal Antibody Revenue by Type (2019-2024)
4.2.2 Global PD-1 and PD-L1 Monoclonal Antibody Revenue by Type (2025-2030)
4.2.3 Global PD-1 and PD-L1 Monoclonal Antibody Revenue Market Share by Type (2019-2030)
4.3 Global PD-1 and PD-L1 Monoclonal Antibody Price by Type (2019-2030)
5 Segment by Application
5.1 Global PD-1 and PD-L1 Monoclonal Antibody Sales by Application (2019-2030)
5.1.1 Global PD-1 and PD-L1 Monoclonal Antibody Sales by Application (2019-2024)
5.1.2 Global PD-1 and PD-L1 Monoclonal Antibody Sales by Application (2025-2030)
5.1.3 Global PD-1 and PD-L1 Monoclonal Antibody Sales Market Share by Application (2019-2030)
5.2 Global PD-1 and PD-L1 Monoclonal Antibody Revenue by Application (2019-2030)
5.2.1 Global PD-1 and PD-L1 Monoclonal Antibody Revenue by Application (2019-2024)
5.2.2 Global PD-1 and PD-L1 Monoclonal Antibody Revenue by Application (2025-2030)
5.2.3 Global PD-1 and PD-L1 Monoclonal Antibody Revenue Market Share by Application (2019-2030)
5.3 Global PD-1 and PD-L1 Monoclonal Antibody Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Merk
6.1.1 Merk Corporation Information
6.1.2 Merk Description and Business Overview
6.1.3 Merk PD-1 and PD-L1 Monoclonal Antibody Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Merk PD-1 and PD-L1 Monoclonal Antibody Product Portfolio
6.1.5 Merk Recent Developments/Updates
6.2 Bristol-Myers Squibb Company
6.2.1 Bristol-Myers Squibb Company Corporation Information
6.2.2 Bristol-Myers Squibb Company Description and Business Overview
6.2.3 Bristol-Myers Squibb Company PD-1 and PD-L1 Monoclonal Antibody Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Bristol-Myers Squibb Company PD-1 and PD-L1 Monoclonal Antibody Product Portfolio
6.2.5 Bristol-Myers Squibb Company Recent Developments/Updates
6.3 Roche
6.3.1 Roche Corporation Information
6.3.2 Roche Description and Business Overview
6.3.3 Roche PD-1 and PD-L1 Monoclonal Antibody Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Roche PD-1 and PD-L1 Monoclonal Antibody Product Portfolio
6.3.5 Roche Recent Developments/Updates
6.4 Pfizer
6.4.1 Pfizer Corporation Information
6.4.2 Pfizer Description and Business Overview
6.4.3 Pfizer PD-1 and PD-L1 Monoclonal Antibody Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Pfizer PD-1 and PD-L1 Monoclonal Antibody Product Portfolio
6.4.5 Pfizer Recent Developments/Updates
6.5 AstraZeneca
6.5.1 AstraZeneca Corporation Information
6.5.2 AstraZeneca Description and Business Overview
6.5.3 AstraZeneca PD-1 and PD-L1 Monoclonal Antibody Sales, Revenue and Gross Margin (2019-2024)
6.5.4 AstraZeneca PD-1 and PD-L1 Monoclonal Antibody Product Portfolio
6.5.5 AstraZeneca Recent Developments/Updates
6.6 Junshi Biosciences
6.6.1 Junshi Biosciences Corporation Information
6.6.2 Junshi Biosciences Description and Business Overview
6.6.3 Junshi Biosciences PD-1 and PD-L1 Monoclonal Antibody Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Junshi Biosciences PD-1 and PD-L1 Monoclonal Antibody Product Portfolio
6.6.5 Junshi Biosciences Recent Developments/Updates
6.7 Innovent
6.6.1 Innovent Corporation Information
6.6.2 Innovent Description and Business Overview
6.6.3 Innovent PD-1 and PD-L1 Monoclonal Antibody Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Innovent PD-1 and PD-L1 Monoclonal Antibody Product Portfolio
6.7.5 Innovent Recent Developments/Updates
6.8 Hengrui
6.8.1 Hengrui Corporation Information
6.8.2 Hengrui Description and Business Overview
6.8.3 Hengrui PD-1 and PD-L1 Monoclonal Antibody Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Hengrui PD-1 and PD-L1 Monoclonal Antibody Product Portfolio
6.8.5 Hengrui Recent Developments/Updates
6.9 BeiGene
6.9.1 BeiGene Corporation Information
6.9.2 BeiGene Description and Business Overview
6.9.3 BeiGene PD-1 and PD-L1 Monoclonal Antibody Sales, Revenue and Gross Margin (2019-2024)
6.9.4 BeiGene PD-1 and PD-L1 Monoclonal Antibody Product Portfolio
6.9.5 BeiGene Recent Developments/Updates
6.10 Alphamab Oncology
6.10.1 Alphamab Oncology Corporation Information
6.10.2 Alphamab Oncology Description and Business Overview
6.10.3 Alphamab Oncology PD-1 and PD-L1 Monoclonal Antibody Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Alphamab Oncology PD-1 and PD-L1 Monoclonal Antibody Product Portfolio
6.10.5 Alphamab Oncology Recent Developments/Updates
6.11 Cstone
6.11.1 Cstone Corporation Information
6.11.2 Cstone PD-1 and PD-L1 Monoclonal Antibody Description and Business Overview
6.11.3 Cstone PD-1 and PD-L1 Monoclonal Antibody Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Cstone PD-1 and PD-L1 Monoclonal Antibody Product Portfolio
6.11.5 Cstone Recent Developments/Updates
6.12 Akeso
6.12.1 Akeso Corporation Information
6.12.2 Akeso PD-1 and PD-L1 Monoclonal Antibody Description and Business Overview
6.12.3 Akeso PD-1 and PD-L1 Monoclonal Antibody Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Akeso PD-1 and PD-L1 Monoclonal Antibody Product Portfolio
6.12.5 Akeso Recent Developments/Updates
6.13 Henlius Biotech
6.13.1 Henlius Biotech Corporation Information
6.13.2 Henlius Biotech PD-1 and PD-L1 Monoclonal Antibody Description and Business Overview
6.13.3 Henlius Biotech PD-1 and PD-L1 Monoclonal Antibody Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Henlius Biotech PD-1 and PD-L1 Monoclonal Antibody Product Portfolio
6.13.5 Henlius Biotech Recent Developments/Updates
6.14 Lepu Biopharma
6.14.1 Lepu Biopharma Corporation Information
6.14.2 Lepu Biopharma PD-1 and PD-L1 Monoclonal Antibody Description and Business Overview
6.14.3 Lepu Biopharma PD-1 and PD-L1 Monoclonal Antibody Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Lepu Biopharma PD-1 and PD-L1 Monoclonal Antibody Product Portfolio
6.14.5 Lepu Biopharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 PD-1 and PD-L1 Monoclonal Antibody Industry Chain Analysis
7.2 PD-1 and PD-L1 Monoclonal Antibody Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 PD-1 and PD-L1 Monoclonal Antibody Production Mode & Process
7.4 PD-1 and PD-L1 Monoclonal Antibody Sales and Marketing
7.4.1 PD-1 and PD-L1 Monoclonal Antibody Sales Channels
7.4.2 PD-1 and PD-L1 Monoclonal Antibody Distributors
7.5 PD-1 and PD-L1 Monoclonal Antibody Customers
8 PD-1 and PD-L1 Monoclonal Antibody Market Dynamics
8.1 PD-1 and PD-L1 Monoclonal Antibody Industry Trends
8.2 PD-1 and PD-L1 Monoclonal Antibody Market Drivers
8.3 PD-1 and PD-L1 Monoclonal Antibody Market Challenges
8.4 PD-1 and PD-L1 Monoclonal Antibody Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
List of Tables
Table 1. Global PD-1 and PD-L1 Monoclonal Antibody Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global PD-1 and PD-L1 Monoclonal Antibody Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global PD-1 and PD-L1 Monoclonal Antibody Market Competitive Situation by Manufacturers in 2023
Table 4. Global PD-1 and PD-L1 Monoclonal Antibody Sales (Units) of Key Manufacturers (2019-2024)
Table 5. Global PD-1 and PD-L1 Monoclonal Antibody Sales Market Share by Manufacturers (2019-2024)
Table 6. Global PD-1 and PD-L1 Monoclonal Antibody Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global PD-1 and PD-L1 Monoclonal Antibody Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market PD-1 and PD-L1 Monoclonal Antibody Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of PD-1 and PD-L1 Monoclonal Antibody, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of PD-1 and PD-L1 Monoclonal Antibody, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of PD-1 and PD-L1 Monoclonal Antibody, Product Type & Application
Table 12. Global Key Manufacturers of PD-1 and PD-L1 Monoclonal Antibody, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global PD-1 and PD-L1 Monoclonal Antibody by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PD-1 and PD-L1 Monoclonal Antibody as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global PD-1 and PD-L1 Monoclonal Antibody Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global PD-1 and PD-L1 Monoclonal Antibody Sales by Region (2019-2024) & (Units)
Table 18. Global PD-1 and PD-L1 Monoclonal Antibody Sales Market Share by Region (2019-2024)
Table 19. Global PD-1 and PD-L1 Monoclonal Antibody Sales by Region (2025-2030) & (Units)
Table 20. Global PD-1 and PD-L1 Monoclonal Antibody Sales Market Share by Region (2025-2030)
Table 21. Global PD-1 and PD-L1 Monoclonal Antibody Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global PD-1 and PD-L1 Monoclonal Antibody Revenue Market Share by Region (2019-2024)
Table 23. Global PD-1 and PD-L1 Monoclonal Antibody Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global PD-1 and PD-L1 Monoclonal Antibody Revenue Market Share by Region (2025-2030)
Table 25. North America PD-1 and PD-L1 Monoclonal Antibody Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America PD-1 and PD-L1 Monoclonal Antibody Sales by Country (2019-2024) & (Units)
Table 27. North America PD-1 and PD-L1 Monoclonal Antibody Sales by Country (2025-2030) & (Units)
Table 28. North America PD-1 and PD-L1 Monoclonal Antibody Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America PD-1 and PD-L1 Monoclonal Antibody Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe PD-1 and PD-L1 Monoclonal Antibody Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe PD-1 and PD-L1 Monoclonal Antibody Sales by Country (2019-2024) & (Units)
Table 32. Europe PD-1 and PD-L1 Monoclonal Antibody Sales by Country (2025-2030) & (Units)
Table 33. Europe PD-1 and PD-L1 Monoclonal Antibody Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe PD-1 and PD-L1 Monoclonal Antibody Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific PD-1 and PD-L1 Monoclonal Antibody Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific PD-1 and PD-L1 Monoclonal Antibody Sales by Region (2019-2024) & (Units)
Table 37. Asia Pacific PD-1 and PD-L1 Monoclonal Antibody Sales by Region (2025-2030) & (Units)
Table 38. Asia Pacific PD-1 and PD-L1 Monoclonal Antibody Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific PD-1 and PD-L1 Monoclonal Antibody Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America PD-1 and PD-L1 Monoclonal Antibody Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America PD-1 and PD-L1 Monoclonal Antibody Sales by Country (2019-2024) & (Units)
Table 42. Latin America PD-1 and PD-L1 Monoclonal Antibody Sales by Country (2025-2030) & (Units)
Table 43. Latin America PD-1 and PD-L1 Monoclonal Antibody Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America PD-1 and PD-L1 Monoclonal Antibody Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa PD-1 and PD-L1 Monoclonal Antibody Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa PD-1 and PD-L1 Monoclonal Antibody Sales by Country (2019-2024) & (Units)
Table 47. Middle East & Africa PD-1 and PD-L1 Monoclonal Antibody Sales by Country (2025-2030) & (Units)
Table 48. Middle East & Africa PD-1 and PD-L1 Monoclonal Antibody Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa PD-1 and PD-L1 Monoclonal Antibody Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global PD-1 and PD-L1 Monoclonal Antibody Sales (Units) by Type (2019-2024)
Table 51. Global PD-1 and PD-L1 Monoclonal Antibody Sales (Units) by Type (2025-2030)
Table 52. Global PD-1 and PD-L1 Monoclonal Antibody Sales Market Share by Type (2019-2024)
Table 53. Global PD-1 and PD-L1 Monoclonal Antibody Sales Market Share by Type (2025-2030)
Table 54. Global PD-1 and PD-L1 Monoclonal Antibody Revenue (US$ Million) by Type (2019-2024)
Table 55. Global PD-1 and PD-L1 Monoclonal Antibody Revenue (US$ Million) by Type (2025-2030)
Table 56. Global PD-1 and PD-L1 Monoclonal Antibody Revenue Market Share by Type (2019-2024)
Table 57. Global PD-1 and PD-L1 Monoclonal Antibody Revenue Market Share by Type (2025-2030)
Table 58. Global PD-1 and PD-L1 Monoclonal Antibody Price (US$/Unit) by Type (2019-2024)
Table 59. Global PD-1 and PD-L1 Monoclonal Antibody Price (US$/Unit) by Type (2025-2030)
Table 60. Global PD-1 and PD-L1 Monoclonal Antibody Sales (Units) by Application (2019-2024)
Table 61. Global PD-1 and PD-L1 Monoclonal Antibody Sales (Units) by Application (2025-2030)
Table 62. Global PD-1 and PD-L1 Monoclonal Antibody Sales Market Share by Application (2019-2024)
Table 63. Global PD-1 and PD-L1 Monoclonal Antibody Sales Market Share by Application (2025-2030)
Table 64. Global PD-1 and PD-L1 Monoclonal Antibody Revenue (US$ Million) by Application (2019-2024)
Table 65. Global PD-1 and PD-L1 Monoclonal Antibody Revenue (US$ Million) by Application (2025-2030)
Table 66. Global PD-1 and PD-L1 Monoclonal Antibody Revenue Market Share by Application (2019-2024)
Table 67. Global PD-1 and PD-L1 Monoclonal Antibody Revenue Market Share by Application (2025-2030)
Table 68. Global PD-1 and PD-L1 Monoclonal Antibody Price (US$/Unit) by Application (2019-2024)
Table 69. Global PD-1 and PD-L1 Monoclonal Antibody Price (US$/Unit) by Application (2025-2030)
Table 70. Merk Corporation Information
Table 71. Merk Description and Business Overview
Table 72. Merk PD-1 and PD-L1 Monoclonal Antibody Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Merk PD-1 and PD-L1 Monoclonal Antibody Product
Table 74. Merk Recent Developments/Updates
Table 75. Bristol-Myers Squibb Company Corporation Information
Table 76. Bristol-Myers Squibb Company Description and Business Overview
Table 77. Bristol-Myers Squibb Company PD-1 and PD-L1 Monoclonal Antibody Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Bristol-Myers Squibb Company PD-1 and PD-L1 Monoclonal Antibody Product
Table 79. Bristol-Myers Squibb Company Recent Developments/Updates
Table 80. Roche Corporation Information
Table 81. Roche Description and Business Overview
Table 82. Roche PD-1 and PD-L1 Monoclonal Antibody Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Roche PD-1 and PD-L1 Monoclonal Antibody Product
Table 84. Roche Recent Developments/Updates
Table 85. Pfizer Corporation Information
Table 86. Pfizer Description and Business Overview
Table 87. Pfizer PD-1 and PD-L1 Monoclonal Antibody Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Pfizer PD-1 and PD-L1 Monoclonal Antibody Product
Table 89. Pfizer Recent Developments/Updates
Table 90. AstraZeneca Corporation Information
Table 91. AstraZeneca Description and Business Overview
Table 92. AstraZeneca PD-1 and PD-L1 Monoclonal Antibody Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. AstraZeneca PD-1 and PD-L1 Monoclonal Antibody Product
Table 94. AstraZeneca Recent Developments/Updates
Table 95. Junshi Biosciences Corporation Information
Table 96. Junshi Biosciences Description and Business Overview
Table 97. Junshi Biosciences PD-1 and PD-L1 Monoclonal Antibody Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Junshi Biosciences PD-1 and PD-L1 Monoclonal Antibody Product
Table 99. Junshi Biosciences Recent Developments/Updates
Table 100. Innovent Corporation Information
Table 101. Innovent Description and Business Overview
Table 102. Innovent PD-1 and PD-L1 Monoclonal Antibody Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Innovent PD-1 and PD-L1 Monoclonal Antibody Product
Table 104. Innovent Recent Developments/Updates
Table 105. Hengrui Corporation Information
Table 106. Hengrui Description and Business Overview
Table 107. Hengrui PD-1 and PD-L1 Monoclonal Antibody Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Hengrui PD-1 and PD-L1 Monoclonal Antibody Product
Table 109. Hengrui Recent Developments/Updates
Table 110. BeiGene Corporation Information
Table 111. BeiGene Description and Business Overview
Table 112. BeiGene PD-1 and PD-L1 Monoclonal Antibody Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. BeiGene PD-1 and PD-L1 Monoclonal Antibody Product
Table 114. BeiGene Recent Developments/Updates
Table 115. Alphamab Oncology Corporation Information
Table 116. Alphamab Oncology Description and Business Overview
Table 117. Alphamab Oncology PD-1 and PD-L1 Monoclonal Antibody Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Alphamab Oncology PD-1 and PD-L1 Monoclonal Antibody Product
Table 119. Alphamab Oncology Recent Developments/Updates
Table 120. Cstone Corporation Information
Table 121. Cstone Description and Business Overview
Table 122. Cstone PD-1 and PD-L1 Monoclonal Antibody Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. Cstone PD-1 and PD-L1 Monoclonal Antibody Product
Table 124. Cstone Recent Developments/Updates
Table 125. Akeso Corporation Information
Table 126. Akeso Description and Business Overview
Table 127. Akeso PD-1 and PD-L1 Monoclonal Antibody Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. Akeso PD-1 and PD-L1 Monoclonal Antibody Product
Table 129. Akeso Recent Developments/Updates
Table 130. Henlius Biotech Corporation Information
Table 131. Henlius Biotech Description and Business Overview
Table 132. Henlius Biotech PD-1 and PD-L1 Monoclonal Antibody Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 133. Henlius Biotech PD-1 and PD-L1 Monoclonal Antibody Product
Table 134. Henlius Biotech Recent Developments/Updates
Table 135. Lepu Biopharma Corporation Information
Table 136. Lepu Biopharma Description and Business Overview
Table 137. Lepu Biopharma PD-1 and PD-L1 Monoclonal Antibody Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 138. Lepu Biopharma PD-1 and PD-L1 Monoclonal Antibody Product
Table 139. Lepu Biopharma Recent Developments/Updates
Table 140. Key Raw Materials Lists
Table 141. Raw Materials Key Suppliers Lists
Table 142. PD-1 and PD-L1 Monoclonal Antibody Distributors List
Table 143. PD-1 and PD-L1 Monoclonal Antibody Customers List
Table 144. PD-1 and PD-L1 Monoclonal Antibody Market Trends
Table 145. PD-1 and PD-L1 Monoclonal Antibody Market Drivers
Table 146. PD-1 and PD-L1 Monoclonal Antibody Market Challenges
Table 147. PD-1 and PD-L1 Monoclonal Antibody Market Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of PD-1 and PD-L1 Monoclonal Antibody
Figure 2. Global PD-1 and PD-L1 Monoclonal Antibody Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global PD-1 and PD-L1 Monoclonal Antibody Market Share by Type in 2023 & 2030
Figure 4. PD-1 Product Picture
Figure 5. PD-L1 Product Picture
Figure 6. Global PD-1 and PD-L1 Monoclonal Antibody Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global PD-1 and PD-L1 Monoclonal Antibody Market Share by Application in 2023 & 2030
Figure 8. Hospital
Figure 9. Other Medical Institutions
Figure 10. Global PD-1 and PD-L1 Monoclonal Antibody Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 11. Global PD-1 and PD-L1 Monoclonal Antibody Market Size (2019-2030) & (US$ Million)
Figure 12. Global PD-1 and PD-L1 Monoclonal Antibody Sales (2019-2030) & (Units)
Figure 13. Global PD-1 and PD-L1 Monoclonal Antibody Average Price (US$/Unit) & (2019-2030)
Figure 14. PD-1 and PD-L1 Monoclonal Antibody Report Years Considered
Figure 15. PD-1 and PD-L1 Monoclonal Antibody Sales Share by Manufacturers in 2023
Figure 16. Global PD-1 and PD-L1 Monoclonal Antibody Revenue Share by Manufacturers in 2023
Figure 17. The Global 5 and 10 Largest PD-1 and PD-L1 Monoclonal Antibody Players: Market Share by Revenue in 2023
Figure 18. PD-1 and PD-L1 Monoclonal Antibody Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 19. Global PD-1 and PD-L1 Monoclonal Antibody Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 20. North America PD-1 and PD-L1 Monoclonal Antibody Sales Market Share by Country (2019-2030)
Figure 21. North America PD-1 and PD-L1 Monoclonal Antibody Revenue Market Share by Country (2019-2030)
Figure 22. U.S. PD-1 and PD-L1 Monoclonal Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 23. Canada PD-1 and PD-L1 Monoclonal Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Europe PD-1 and PD-L1 Monoclonal Antibody Sales Market Share by Country (2019-2030)
Figure 25. Europe PD-1 and PD-L1 Monoclonal Antibody Revenue Market Share by Country (2019-2030)
Figure 26. Germany PD-1 and PD-L1 Monoclonal Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. France PD-1 and PD-L1 Monoclonal Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. U.K. PD-1 and PD-L1 Monoclonal Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. Italy PD-1 and PD-L1 Monoclonal Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Russia PD-1 and PD-L1 Monoclonal Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Asia Pacific PD-1 and PD-L1 Monoclonal Antibody Sales Market Share by Region (2019-2030)
Figure 32. Asia Pacific PD-1 and PD-L1 Monoclonal Antibody Revenue Market Share by Region (2019-2030)
Figure 33. China PD-1 and PD-L1 Monoclonal Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Japan PD-1 and PD-L1 Monoclonal Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. South Korea PD-1 and PD-L1 Monoclonal Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. India PD-1 and PD-L1 Monoclonal Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Australia PD-1 and PD-L1 Monoclonal Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Taiwan PD-1 and PD-L1 Monoclonal Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Indonesia PD-1 and PD-L1 Monoclonal Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Thailand PD-1 and PD-L1 Monoclonal Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Malaysia PD-1 and PD-L1 Monoclonal Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Philippines PD-1 and PD-L1 Monoclonal Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Latin America PD-1 and PD-L1 Monoclonal Antibody Sales Market Share by Country (2019-2030)
Figure 44. Latin America PD-1 and PD-L1 Monoclonal Antibody Revenue Market Share by Country (2019-2030)
Figure 45. Mexico PD-1 and PD-L1 Monoclonal Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Brazil PD-1 and PD-L1 Monoclonal Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Argentina PD-1 and PD-L1 Monoclonal Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Middle East & Africa PD-1 and PD-L1 Monoclonal Antibody Sales Market Share by Country (2019-2030)
Figure 49. Middle East & Africa PD-1 and PD-L1 Monoclonal Antibody Revenue Market Share by Country (2019-2030)
Figure 50. Turkey PD-1 and PD-L1 Monoclonal Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Saudi Arabia PD-1 and PD-L1 Monoclonal Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. U.A.E PD-1 and PD-L1 Monoclonal Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Global Sales Market Share of PD-1 and PD-L1 Monoclonal Antibody by Type (2019-2030)
Figure 54. Global Revenue Market Share of PD-1 and PD-L1 Monoclonal Antibody by Type (2019-2030)
Figure 55. Global PD-1 and PD-L1 Monoclonal Antibody Price (US$/Unit) by Type (2019-2030)
Figure 56. Global Sales Market Share of PD-1 and PD-L1 Monoclonal Antibody by Application (2019-2030)
Figure 57. Global Revenue Market Share of PD-1 and PD-L1 Monoclonal Antibody by Application (2019-2030)
Figure 58. Global PD-1 and PD-L1 Monoclonal Antibody Price (US$/Unit) by Application (2019-2030)
Figure 59. PD-1 and PD-L1 Monoclonal Antibody Value Chain
Figure 60. PD-1 and PD-L1 Monoclonal Antibody Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock